ProMune: all 24 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell LymphomasCompletedNCT00880581Phase 2Results posted
- Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast CancerTerminatedNCT00824733Phase 2Results posted
- Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin LymphomaCompletedNCT00438880Phase 1/2Results posted
- CPG 7909 + Local Radiotherapy in Recurrent Low-Grade LymphomasCompletedNCT00185965Phase 1/2Results posted
- Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 AdjuvantTerminatedNCT01164514Phase 1
- Vaccine Therapy in Preventing Cytomegalovirus in Healthy ParticipantsCompletedNCT00722839Phase 1
- Immune Response to Toll-Like Receptor 9-Agonist Adjuvanted Pneumococcal Vaccination in HIV Infected AdultsCompletedNCT00562939Phase 1/2
- Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT00471471Phase 1
- A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.WithdrawnNCT00471159Phase 2
- Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung CancerCompletedNCT00321815Phase 2
- Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung CancerTerminatedNCT00321308Phase 2
- Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 AdjuvantCompletedNCT00320658Phase 1
- Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLCTerminatedNCT00313768Phase 2
- Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLCTerminatedNCT00254904Phase 3
- Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00254891Phase 3
- A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously TreatedCompletedNCT00233506Phase 1
- Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides.WithdrawnNCT00226993Phase 1/2
- Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected PeopleCompletedNCT00100633Phase 1/2
- CPG 7909 Injection in MelanomaCompletedNCT00070642Phase 2
- CPG 7909 Injection in Non-Small Cell Lung CancerCompletedNCT00070629Phase 2
- CPG 7909 in Patients With Cutaneous T-Cell LymphomaCompletedNCT00043420Phase 1/2
- CPG 7909 in Patients Wih Stage IV Renal Cell CancerCompletedNCT00043407Phase 1/2
- PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)CompletedNCT00043368Phase 2
- Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast CancerCompletedNCT00031278Phase 1/2